COVID-19 and emerging viral infections: The case for interferon lambda

COVID-19 and emerging viral infections: The case for interferon lambda

File
Piontkivska, H., Prokunina-Olsson, L., Alphonse, N., Dickenson, R., Durbin, J., Glenn, J., Hartmann, R., Kotenko, S., Lazear, H., O’Brien, T., Odendall, C., Onabajo, O., Santer, D., Reich, N., Wack, A., & Zanoni, I. (2020). COVID-19 and emerging viral infections: The case for interferon lambda (1–). The Journal of experimental medicine. https://doi.org/https://doi.org/10.1084/jem.20200653
Piontkivska, Helen, Ludmila Prokunina-Olsson, Noémie Alphonse, Ruth Dickenson, Joan Durbin, Jeffrey Glenn, Rune Hartmann, et al. 2020. “COVID-19 and Emerging Viral Infections: The Case for Interferon Lambda”. The Journal of experimental medicine. https://doi.org/https://doi.org/10.1084/jem.20200653.
Piontkivska, Helen, et al. COVID-19 and Emerging Viral Infections: The Case for Interferon Lambda. The Journal of experimental medicine, 14 Apr. 2020, https://doi.org/https://doi.org/10.1084/jem.20200653.